AU2001233114A1 - Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence - Google Patents

Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence

Info

Publication number
AU2001233114A1
AU2001233114A1 AU2001233114A AU3311401A AU2001233114A1 AU 2001233114 A1 AU2001233114 A1 AU 2001233114A1 AU 2001233114 A AU2001233114 A AU 2001233114A AU 3311401 A AU3311401 A AU 3311401A AU 2001233114 A1 AU2001233114 A1 AU 2001233114A1
Authority
AU
Australia
Prior art keywords
predicting
confirming
methods
genomic sequence
information derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001233114A
Other languages
English (en)
Inventor
David Kagen Hanzel
Sharron Gaynor Penn
David Russell Rank
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aeomica Inc
Original Assignee
ANNOMAX Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0024263A external-priority patent/GB2360284B/en
Application filed by ANNOMAX Inc filed Critical ANNOMAX Inc
Publication of AU2001233114A1 publication Critical patent/AU2001233114A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1089—Design, preparation, screening or analysis of libraries using computer algorithms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/60—Fusion polypeptide containing spectroscopic/fluorescent detection, e.g. green fluorescent protein [GFP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B45/00—ICT specially adapted for bioinformatics-related data visualisation, e.g. displaying of maps or networks

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cell Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2001233114A 2000-02-04 2001-01-29 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence Abandoned AU2001233114A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US18031200P 2000-02-04 2000-02-04
US60/180,312 2000-02-04
US20745600P 2000-05-26 2000-05-26
US60/207,456 2000-05-26
US60840800A 2000-06-30 2000-06-30
US09/608,408 2000-06-30
US63236600A 2000-08-03 2000-08-03
US09/632,366 2000-08-03
US23468700P 2000-09-21 2000-09-21
US60/234,687 2000-09-21
US23635900P 2000-09-27 2000-09-27
US60/236,359 2000-09-27
GB0024263.6 2000-10-04
GB0024263A GB2360284B (en) 2000-02-04 2000-10-04 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
PCT/US2001/002967 WO2001057251A2 (fr) 2000-02-04 2001-01-29 Procedes et appareil destines a predire, a confirmer, et a afficher des informations fonctionnelles derivees d'une sequence genomique

Publications (1)

Publication Number Publication Date
AU2001233114A1 true AU2001233114A1 (en) 2001-08-14

Family

ID=27562579

Family Applications (12)

Application Number Title Priority Date Filing Date
AU2001233114A Abandoned AU2001233114A1 (en) 2000-02-04 2001-01-29 Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
AU3087801A Pending AU3087801A (en) 2000-02-04 2001-01-29 Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
AU2001236589A Abandoned AU2001236589A1 (en) 2000-02-04 2001-01-29 Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
AU2001230880A Abandoned AU2001230880A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta
AU2001232758A Abandoned AU2001232758A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
AU2001230879A Abandoned AU2001230879A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells
AU2001232757A Abandoned AU2001232757A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
AU2001230881A Abandoned AU2001230881A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
AU2001232760A Abandoned AU2001232760A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver
AU2001230882A Abandoned AU2001230882A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
AU2001232759A Abandoned AU2001232759A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
AU2001230883A Abandoned AU2001230883A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells

Family Applications After (11)

Application Number Title Priority Date Filing Date
AU3087801A Pending AU3087801A (en) 2000-02-04 2001-01-29 Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
AU2001236589A Abandoned AU2001236589A1 (en) 2000-02-04 2001-01-29 Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
AU2001230880A Abandoned AU2001230880A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta
AU2001232758A Abandoned AU2001232758A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human lung
AU2001230879A Abandoned AU2001230879A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and bt 474 cells
AU2001232757A Abandoned AU2001232757A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human adult liver
AU2001230881A Abandoned AU2001230881A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human heart
AU2001232760A Abandoned AU2001232760A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver
AU2001230882A Abandoned AU2001230882A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
AU2001232759A Abandoned AU2001232759A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human brain
AU2001230883A Abandoned AU2001230883A1 (en) 2000-02-04 2001-01-30 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human hela cells or other human cervical epithelial cells

Country Status (5)

Country Link
US (1) US20020081590A1 (fr)
EP (11) EP1290217A2 (fr)
AU (12) AU2001233114A1 (fr)
GB (11) GB2373500B (fr)
WO (12) WO2001057252A2 (fr)

Families Citing this family (191)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8212000B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8258260B2 (en) 1970-02-11 2012-09-04 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US8211999B2 (en) 1970-02-11 2012-07-03 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7579160B2 (en) 1998-03-18 2009-08-25 Corixa Corporation Methods for the detection of cervical cancer
US7258860B2 (en) 1998-03-18 2007-08-21 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6696247B2 (en) 1998-03-18 2004-02-24 Corixa Corporation Compounds and methods for therapy and diagnosis of lung cancer
US6960570B2 (en) 1998-03-18 2005-11-01 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US6833438B1 (en) 1999-06-01 2004-12-21 Agensys, Inc. Serpentine transmembrane antigens expressed in human cancers and uses thereof
PT1086223E (pt) 1998-06-01 2009-11-03 Agensys Inc Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações
US20030149531A1 (en) 2000-12-06 2003-08-07 Hubert Rene S. Serpentine transmembrane antigens expressed in human cancers and uses thereof
JP4315301B2 (ja) * 1998-10-30 2009-08-19 独立行政法人科学技術振興機構 ヒトＨ３７タンパク質と、このタンパク質をコードする ｃＤＮＡ
US6858710B2 (en) 1998-12-17 2005-02-22 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6962980B2 (en) 1999-09-24 2005-11-08 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6699664B1 (en) 1998-12-17 2004-03-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of ovarian cancer
US6468546B1 (en) 1998-12-17 2002-10-22 Corixa Corporation Compositions and methods for therapy and diagnosis of ovarian cancer
US7888477B2 (en) 1998-12-17 2011-02-15 Corixa Corporation Ovarian cancer-associated antibodies and kits
US6969518B2 (en) 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6844325B2 (en) 1998-12-28 2005-01-18 Corixa Corporation Compositions for the treatment and diagnosis of breast cancer and methods for their use
US6943235B1 (en) 1999-04-12 2005-09-13 Agensys, Inc. Transmembrane protein expressed in prostate cancer
US7244827B2 (en) 2000-04-12 2007-07-17 Agensys, Inc. Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
CA2392510A1 (fr) 1999-11-30 2001-06-07 Corixa Corporation Compositions et methodes destinees au traitement et au diagnostic du cancer du sein
US20020048777A1 (en) 1999-12-06 2002-04-25 Shujath Ali Method of diagnosing monitoring, staging, imaging and treating prostate cancer
JP2004500082A (ja) * 2000-02-03 2004-01-08 ハイセック，インコーポレーテッド ニューロトリミン様ポリペプチドおよびポリヌクレオチドに関する方法と材料
US7811574B2 (en) 2000-02-23 2010-10-12 Glaxosmithkline Biologicals S.A. Tumour-specific animal proteins
JP5502253B2 (ja) 2000-02-23 2014-05-28 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 新規化合物
JP2004500825A (ja) 2000-03-03 2004-01-15 トゥラリック　インコーポレイテッド Ｋｃｎｂ：新規なカリウムチャネルタンパク質
EP1472352A4 (fr) * 2000-03-06 2005-10-12 Smithkline Beecham Corp Nouveaux composes
WO2001075093A1 (fr) * 2000-03-31 2001-10-11 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
US6774209B1 (en) 2000-04-03 2004-08-10 Dyax Corp. Binding peptides for carcinoembryonic antigen (CEA)
KR100378949B1 (ko) 2000-05-13 2003-04-08 주식회사 리젠 바이오텍 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체
WO2001092524A2 (fr) * 2000-05-26 2001-12-06 Aeomica, Inc. Gene du type myosine exprime dans le coeur et les muscles humains
GB2380197A (en) * 2000-05-26 2003-04-02 Aeomica Inc Myosin-like gene expressed in human heart and muscle
US6582935B2 (en) * 2000-05-30 2003-06-24 Applera Corporation Isolated nucleic acid molecules encoding human aspartate aminotransferase protein and uses thereof
US6737062B2 (en) 2000-05-31 2004-05-18 Genzyme Corporation Immunogenic compositions
AU2001265157A1 (en) * 2000-05-31 2001-12-11 Zymogenetics Inc. Mammalian transforming growth factor beta-10
US20020082210A1 (en) * 2000-06-05 2002-06-27 Curtis Rory A.J. 56201, a novel human sodium ion channel family member and uses thereof
ES2659877T3 (es) * 2000-06-05 2018-03-19 The Brigham And Women's Hospital, Inc. Un gen que codifica un homólogo de glicoproteína p humana multifármaco-resistente en el cromosoma 7p15-21 y usos del mismo
AU2001266813A1 (en) * 2000-06-07 2001-12-17 Curagen Corporation Human proteins and nucleic acids encoding same
US20020019028A1 (en) * 2000-06-13 2002-02-14 Kabir Chaturvedi Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
CA2309371A1 (fr) 2000-06-16 2001-12-16 Christopher J. Ong Methode d'identification par sequencage des genes
AU2001281969A1 (en) * 2000-07-17 2002-01-30 Bayer Aktiengesellschaft Regulation of human carboxylesterase-like enzyme
US20030165843A1 (en) * 2000-07-28 2003-09-04 Avi Shoshan Oligonucleotide library for detecting RNA transcripts and splice variants that populate a transcriptome
AU2001283062A1 (en) 2000-08-02 2002-02-13 The Johns Hopkins University Endothelial cell expression patterns
ATE329025T1 (de) * 2000-08-18 2006-06-15 Merck Patent Gmbh Mfq-111, ein menschliches gtpase-ähnlichers protein
US6713257B2 (en) 2000-08-25 2004-03-30 Rosetta Inpharmatics Llc Gene discovery using microarrays
US7807447B1 (en) * 2000-08-25 2010-10-05 Merck Sharp & Dohme Corp. Compositions and methods for exon profiling
AU2001232835A1 (en) * 2000-08-28 2002-03-13 Human Genome Sciences, Inc. 18 human secreted proteins
US6391606B1 (en) * 2000-09-14 2002-05-21 Pe Corporation Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof
GB0022670D0 (en) 2000-09-15 2000-11-01 Astrazeneca Ab Molecules
AU2001294699A1 (en) * 2000-09-23 2002-04-29 New York Blood Center Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
AU2001293863A1 (en) * 2000-10-05 2002-04-15 Bayer Aktiengesellschaft Regulation of human sodium-dependent monoamine transporter
US6584419B1 (en) * 2000-10-12 2003-06-24 Agilent Technologies, Inc. System and method for enabling an operator to analyze a database of acquired signal pulse characteristics
EP1332157A2 (fr) 2000-11-03 2003-08-06 The Regents of the University of California Polypeptides de prokineticine, et methodes et compositions associees
WO2002079248A2 (fr) * 2000-11-17 2002-10-10 Zymogenetics, Inc. Proteine 53 alpha helicoidale secretee par des mammiferes
WO2002046477A2 (fr) 2000-12-07 2002-06-13 Chiron Corporation Retrovirus endogenes regules positivement dans le cancer de la prostate
WO2002053593A1 (fr) * 2000-12-28 2002-07-11 Takeda Chemical Industries, Ltd. Nouvelle proteine de recepteur couple a la proteine g et adn de celle-ci
EP1373526A4 (fr) * 2001-03-08 2006-01-25 Curagen Corp Polypeptides therapeutiques, les acides nucleiques les codant et leurs procedes d'utilisation
CA2441670A1 (fr) * 2001-03-21 2002-10-03 Hyseq, Inc. Nouveaux acides nucleiques et polypeptides
US20030105003A1 (en) 2001-04-05 2003-06-05 Jan Nilsson Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
SE0103754L (sv) * 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
US20030191073A1 (en) 2001-11-07 2003-10-09 Challita-Eid Pia M. Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
EP2280030A3 (fr) 2001-04-10 2011-06-15 Agensys, Inc. Acides nucléiques et protéines correspondantes utiles dans la détection et le traitement des différents cancers
US7811575B2 (en) 2001-04-10 2010-10-12 Agensys, Inc. Nucleic acids and corresponding proteins entitled 158P3D2 useful in treatment and detection of cancer
WO2002083928A2 (fr) 2001-04-10 2002-10-24 Agensys, Inc. Acide nucleique et proteine correspondante intitule 158p3d2 utiles dans le traitement et la detection du cancer
DK1573022T3 (da) 2001-04-10 2011-09-12 Agensys Inc Nukleinsyre og tilsvarende protein betegnet 184P1E2, der er egnede til behandling og påvisning af cancer
US20030235821A1 (en) * 2001-06-04 2003-12-25 Zerhusen Bryan D. Novel Human proteins, polynucleotides encoding them and methods of using the same
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7833779B2 (en) * 2001-07-25 2010-11-16 Jivan Biologies Inc. Methods and systems for polynucleotide detection
US7340349B2 (en) * 2001-07-25 2008-03-04 Jonathan Bingham Method and system for identifying splice variants of a gene
DE60230046D1 (de) * 2001-08-10 2009-01-08 Novartis Ag Peptide, die atherosklerotische schädigungen binden
JP2005505271A (ja) 2001-09-06 2005-02-24 アジェンシス， インコーポレイテッド 癌の処置および検出において有用なｓｔｅａｐ−１と名称が与えられる核酸および対応するタンパク質
US7494646B2 (en) 2001-09-06 2009-02-24 Agensys, Inc. Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
US20050222070A1 (en) 2002-05-29 2005-10-06 Develogen Aktiengesellschaft Fuer Entwicklungsbiologische Forschung Pancreas-specific proteins
GB0122789D0 (en) * 2001-09-21 2001-11-14 Babraham Inst Differential gene expression in schizophrenia
EP1295951A1 (fr) * 2001-09-24 2003-03-26 The University of British Columbia Utlilisation des bibliothèques de cellules
NZ532217A (en) 2001-09-28 2006-12-22 Esperion Therapeutics Inc Use of an alpha helical apolipoprotein or HDL associating protein adapted to be administered locally to prevent or reduce stenosis or restenosis or to stabilize a plaque
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
EP1537140B1 (fr) 2001-11-07 2013-01-02 Agensys, Inc. Acide nucleique et proteine correspondante 161p2f10b utiles dans le traitement et le depistage du cancer
IS7221A (is) * 2001-11-15 2004-04-15 Memory Pharmaceuticals Corporation Hringlaga adenosínmónófosfat fosfódíesterasa 4D7 ísóform og aðferðir til notkunar þeirra
WO2003046564A2 (fr) * 2001-11-23 2003-06-05 Syn.X Pharma, Inc. Marqueurs biopolymeres proteiques predictifs de la maladie d'alzheimer
US7172858B2 (en) 2001-11-28 2007-02-06 The General Hospital Corporation Blood-based assay for dysferlinopathies
EP1487989A2 (fr) * 2001-11-28 2004-12-22 Incyte Genomics, Inc. Molecules permettant de detecter et de traiter des maladies
WO2003050307A1 (fr) * 2001-12-05 2003-06-19 Genzyme Corporation Composes destines a la therapie et au diagnostic et procedes d'utilisation associes
WO2003050258A2 (fr) * 2001-12-07 2003-06-19 Chiron Corporation Polypeptides de retrovirus endogenes lies a la transformation oncogenique
KR20030062789A (ko) * 2002-01-19 2003-07-28 포휴먼텍(주) 생체분자 전달 펩타이드 ｓｉｍ2-ｂｔｍ 및 이것을포함하는 생명공학제품
US20060088830A1 (en) * 2002-02-21 2006-04-27 Eastern Virginia Medical School Protein biomarkers that distinguish prostate cancer from non-malignant cells
DE10211088A1 (de) * 2002-03-13 2003-09-25 Ugur Sahin Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
US20030194704A1 (en) * 2002-04-03 2003-10-16 Penn Sharron Gaynor Human genome-derived single exon nucleic acid probes useful for gene expression analysis two
IL164376A0 (en) 2002-04-03 2005-12-18 Applied Research Systems Ox4or binding agents, their preparation and pharmaceutical compositions containing them
EP2275118A3 (fr) * 2002-05-29 2011-10-19 DeveloGen Aktiengesellschaft Proteines specifiques du pancreas
CA2489292A1 (fr) 2002-06-13 2003-12-24 Chiron Corporation Vecteurs pour l'expression de polypeptides hml-2
WO2004001060A2 (fr) 2002-06-20 2003-12-31 Bristol-Myers Squibb Company Identification et modulation d'un recepteur couple aux proteines g (rcpg), rai3, associe a la bronchopneumopathie chronique obstructive (bpco) et a la regulation de nf-$g(k)b et de la e-selectine
US9200036B2 (en) 2002-07-12 2015-12-01 The Johns Hopkins University Mesothelin vaccines and model systems
US20050175625A1 (en) 2002-07-12 2005-08-11 The Johns Hopkins University Mesothelin vaccines and model systems
US20090110702A1 (en) 2002-07-12 2009-04-30 The Johns Hopkins University Mesothelin Vaccines and Model Systems and Control of Tumors
AU2003254081A1 (en) 2002-07-24 2004-02-09 New York University Truncated rgr in t cell malignancy
WO2004016733A2 (fr) 2002-08-16 2004-02-26 Agensys, Inc. Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers
EP1567552A2 (fr) * 2002-12-04 2005-08-31 Applied Research Systems ARS Holding N.V. Nouveaux polypeptides analogues a l'ifn gamma
ATE466870T1 (de) * 2002-12-06 2010-05-15 Zhi Cheng Xiao Peptide und deren verwendung in der behandlung von krankheiten des zentralen nervensystems
GB0303006D0 (en) * 2003-02-10 2003-03-12 Genomica Sau A method to detect polymeric nucleic acids
US20050017981A1 (en) * 2003-03-17 2005-01-27 Jonathan Bingham Methods of representing gene product sequences and expression
US20040234963A1 (en) * 2003-05-19 2004-11-25 Sampas Nicholas M. Method and system for analysis of variable splicing of mRNAs by array hybridization
DE10332854A1 (de) * 2003-07-18 2005-02-17 Universitätsklinikum der Charité der Humboldt-Universität zu Berlin Verwendung des neu-identifizierten humanen Gens 7a5/Prognostin für Tumordiagnostik und Tumortherapie
DE602004023096D1 (de) * 2003-08-07 2009-10-22 Hoffmann La Roche Ra antigene peptide
AU2004267067A1 (en) * 2003-08-18 2005-03-03 Wyeth Human LXR alpha variants
EP1522857A1 (fr) 2003-10-09 2005-04-13 Universiteit Maastricht Méthode pour identifier des individus qui risquent de développer une défaillance cardiaque par la détection du taux de galectine-3 ou thrombospondine-2
JP4019147B2 (ja) * 2003-10-31 2007-12-12 独立行政法人農業生物資源研究所 種子特異的プロモーターおよびその利用
PL1694354T3 (pl) 2003-11-27 2009-12-31 Develogen Ag Sposób zapobiegania i leczenia cukrzycy za pomocą neurturyny
WO2005091751A2 (fr) * 2004-03-25 2005-10-06 Medical College Of Georgia Research Institute Nouveau gene associe au diabete de type 1 et procedes d'utilisation
US8926958B2 (en) 2004-04-06 2015-01-06 Cedars-Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein A-I and apolipoprotein A-I milano
SI1742966T1 (sl) 2004-04-22 2014-03-31 Agensys, Inc. Protitelesa in iz njih izvedene molekule, ki se veĹľejo na STEAP-1 proteine
JP4649575B2 (ja) * 2004-05-19 2011-03-09 財団法人ヒューマンサイエンス振興財団 新規ムチン遺伝子及び粘膜関連疾患の診断
WO2006045750A2 (fr) * 2004-10-20 2006-05-04 Friedrich-Alexander- Universität Erlangen- Nürnberg Peptides stimulateurs de lymphocytes t provenant d'un proteoglycane de sulfate de chondroitine associe au melanome et utilisation de ceux-ci
WO2006083792A2 (fr) * 2005-01-31 2006-08-10 Vaxinnate Corporation Nouveaux ligands de polypeptides destines a un recepteur de type toll 2 (tlr2)
CA2603093A1 (fr) 2005-03-31 2006-10-05 Agensys, Inc. Anticorps et molecules correspondantes qui se fixent aux proteines 161p2f10b
US8350009B2 (en) 2005-03-31 2013-01-08 Agensys, Inc. Antibodies and related molecules that bind to 161P2F10B proteins
WO2006128902A1 (fr) * 2005-06-01 2006-12-07 Evotec Neurosciences Gmbh Proteines slc39a12 en tant que cibles diagnostiques et therapeutiques pour les maladies neurodegeneratives
GB0515180D0 (en) * 2005-07-22 2005-08-31 Ares Trading Sa Protein
JP4890806B2 (ja) * 2005-07-27 2012-03-07 富士通株式会社 予測プログラムおよび予測装置
EP1924595A2 (fr) * 2005-08-12 2008-05-28 Cartela R & D AB Nouveaux peptides et utilisations associees
US20070048764A1 (en) * 2005-08-23 2007-03-01 Jonathan Bingham Indicator polynucleotide controls
ATE461214T1 (de) 2005-09-05 2010-04-15 Immatics Biotechnologies Gmbh Tumor-assoziierte peptide, welche an unterschiedliche menschliche leukozytenantigene der klasse ii binden
US7962291B2 (en) 2005-09-30 2011-06-14 Affymetrix, Inc. Methods and computer software for detecting splice variants
FR2892730A1 (fr) * 2005-10-28 2007-05-04 Biomerieux Sa Methode pour detecter la presence ou le risque de developper un cancer
WO2007097469A1 (fr) * 2006-02-24 2007-08-30 Oncotherapy Science, Inc. Peptide dominant negatif d'imp-3, polynucleotide codant pour lui, composition pharmaceutique le contenant et procedes de traitement ou de prevention du cancer
CA2664630C (fr) * 2006-10-10 2018-11-27 Shiv Srivastava Alterations de l'expression du gene erg specifiques au cancer de la prostate, et procedes de detection et de traitement en fonction de ces alterations
ES2636089T3 (es) 2006-10-27 2017-10-05 Genentech, Inc. Anticuerpos e inmunoconjugados y usos para los mismos
WO2008104803A2 (fr) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Protéines
US8999634B2 (en) * 2007-04-27 2015-04-07 Quest Diagnostics Investments Incorporated Nucleic acid detection combining amplification with fragmentation
US8569449B2 (en) * 2007-05-08 2013-10-29 University Of Louisville Research Foundation, Inc. Synthetic peptides and peptide mimetics
AU2008285655B2 (en) * 2007-08-09 2012-03-08 Novartis Ag Thiopeptide precursor protein, gene encoding it and uses thereof
PT2190469E (pt) * 2007-09-04 2015-06-25 Compugen Ltd Polipéptidos e polinucleótidos, e utilizações dos mesmos como um alvo de fármacos para produzir fármacos e agentes biológicos
GB2453589A (en) 2007-10-12 2009-04-15 King S College London Protease inhibition
JP2011508598A (ja) * 2008-01-04 2011-03-17 サントル ナショナル ドゥ ラ ルシェルシュ シアンティフィク 乳癌のインビトロ分子診断
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
EP3118326B1 (fr) 2008-10-27 2020-04-29 Sapporo Medical University Marqueur moléculaire de cellule souche cancéreuse
US8637249B2 (en) 2008-11-14 2014-01-28 Gen-Probe Incorporated Compositions, kits and methods for detection of Campylobacter nucleic acid
WO2010136443A1 (fr) 2009-05-27 2010-12-02 Glaxosmithkline Biologicals S.A. Produits de recombinaison de casb7439
EA201270316A1 (ru) 2009-08-25 2012-09-28 БиДжи МЕДИСИН, ИНК. Галектин-3 и сердечная ресинхронизирующая терапия
US8075895B2 (en) * 2009-09-22 2011-12-13 Janssen Pharmaceutica N.V. Identification of antigenic peptides from multiple myeloma cells
CA2789230C (fr) 2010-02-08 2019-04-02 Agensys, Inc. Conjugues anticorps-medicaments (adc) qui se lient aux proteines 161p2f10b
US20140038834A1 (en) * 2010-07-07 2014-02-06 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patiëntenzorg Novel biomarkers for detecting neuronal loss
CN103501806A (zh) 2010-11-12 2014-01-08 赛达斯西奈医疗中心 用于治疗和/或预防动脉瘤的免疫调节方法和系统
EP2637689A2 (fr) 2010-11-12 2013-09-18 Cedars-Sinai Medical Center Procédés et systèmes immunomodulateurs pour le traitement et/ou la prévention de l'hypertension
WO2012068405A2 (fr) * 2010-11-17 2012-05-24 Isis Pharmaceuticals, Inc. Modulation de l'expression de l'alpha synucléine
WO2012098281A2 (fr) 2011-01-19 2012-07-26 Universidad Miguel Hernández De Elche Peptides modulateurs de récepteurs trp et leurs utilisations
US8494967B2 (en) * 2011-03-11 2013-07-23 Bytemark, Inc. Method and system for distributing electronic tickets with visual display
US20120252026A1 (en) * 2011-04-01 2012-10-04 Harris Reuben S Cancer biomarker, diagnostic methods, and assay reagents
WO2013173827A2 (fr) * 2012-05-18 2013-11-21 Board Of Regents Of The University Of Nebraska Procédés et compositions pour inhiber des maladies du système nerveux central
GB201214746D0 (en) * 2012-08-17 2012-10-03 Cancer Rec Tech Ltd Biomolecular complexes
EP2928918A1 (fr) * 2012-12-07 2015-10-14 Centre National de la Recherche Scientifique (CNRS) Anticorps dirigé contre la protéine trio et son procédé de production
US9384239B2 (en) * 2012-12-17 2016-07-05 Microsoft Technology Licensing, Llc Parallel local sequence alignment
EP3000825A4 (fr) * 2013-05-23 2017-02-08 Ajou University Industry-Academic Cooperation Foundation Peptide transtumoral spécifique de la neuropiline et protéine de fusion comprenant ce peptide fusionné
WO2015020960A1 (fr) * 2013-08-09 2015-02-12 Novartis Ag Nouveaux polynucléotides longs arn non codants (arn lnc)
WO2015050259A1 (fr) * 2013-10-03 2015-04-09 大日本住友製薬株式会社 Peptide d'antigène tumoral
DK3055331T3 (da) 2013-10-11 2021-03-22 Oxford Bio Therapeutics Ltd Konjugerede antistoffer mod ly75 til cancerbehandling
GB201319446D0 (en) * 2013-11-04 2013-12-18 Immatics Biotechnologies Gmbh Personalized immunotherapy against several neuronal and brain tumors
EP2886126B1 (fr) * 2013-12-23 2017-06-07 Exchange Imaging Technologies GmbH Nanoparticule conjuguée á peptides de liaison CD44
US20160340659A1 (en) * 2014-01-30 2016-11-24 Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd. Actin binding peptides and compositions comprising same for inhibiting angiogenesis and treating medical conditions associated with same
EP3108006B1 (fr) * 2014-02-21 2018-08-01 Ventana Medical Systems, Inc. Sondes oligonucléotidiques monocaténaires pour énumération de copies de chromosomes ou de gènes
WO2015153402A1 (fr) * 2014-04-03 2015-10-08 The Regents Of The University Of California Fragments peptidiques de nétrine-1, compositions comprenant ces derniers et méthodes associées
US10302652B2 (en) * 2015-02-17 2019-05-28 Elena SANTONICO Hybrid protein for the identification of neddylated substrates
GB201505305D0 (en) 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
PT3388075T (pt) 2015-03-27 2023-08-18 Immatics Biotechnologies Gmbh Novos péptidos e combinações de péptidos para uso em imunoterapia contra vários tumores
GB201507719D0 (en) * 2015-05-06 2015-06-17 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides and scaffolds thereof for use in immunotherapy against colorectal carcinoma (CRC) and other cancers
GB201513921D0 (en) * 2015-08-05 2015-09-23 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
GB201602918D0 (en) 2016-02-19 2016-04-06 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers
MA55153A (fr) 2016-02-19 2021-09-29 Immatics Biotechnologies Gmbh Nouveaux peptides et combinaison de peptides pour une utilisation dans l'immunothérapie contre le lymphome non hodgkinien et d'autres cancers
WO2018115879A1 (fr) 2016-12-21 2018-06-28 Mereo Biopharma 3 Limited Utilisation d'anticorps anti-sclérostine dans le traitement de l'ostéogenèse imparfaite
JP7174492B2 (ja) * 2017-01-04 2022-11-17 ウォルグ ファーマシューティカルズ （ハンジョウ） カンパニー，リミテッド Ｓ－アレスチンペプチドおよびその治療的使用
DK3565579T3 (da) 2017-01-05 2023-09-04 Kahr Medical Ltd Pd1-41bbl-fusionsprotein og fremgangsmåder til anvendelse deraf
HRP20220230T1 (hr) 2017-01-05 2022-04-29 Kahr Medical Ltd. Sirp1 alfa-41bbl fuzijski protein i metoda njegove upotrebe
WO2018127916A1 (fr) 2017-01-05 2018-07-12 Kahr Medical Ltd. Protéine de fusion pd1-cd70 et ses procédés d'utilisation
US11299530B2 (en) 2017-01-05 2022-04-12 Kahr Medical Ltd. SIRP alpha-CD70 fusion protein and methods of use thereof
BR112019014042A2 (pt) * 2017-01-17 2020-02-04 Illumina Inc determinação de variante de splice oncogênica
JP7320796B2 (ja) 2017-01-30 2023-08-04 国立研究開発法人国立循環器病研究センター 血管内皮系細胞に特異的に結合するペプチドの使用、及びペプチド
JP7017726B2 (ja) 2017-01-30 2022-02-09 国立研究開発法人国立循環器病研究センター 血管内皮系細胞に特異的に結合するペプチドの使用、及びペプチド
EP3382032A1 (fr) * 2017-03-30 2018-10-03 Euroimmun Medizinische Labordiagnostika AG Dosage pour le diagnostic de la dermatophytose
KR102667951B1 (ko) 2017-04-03 2024-05-22 에프. 호프만-라 로슈 아게 Steap-1에 결합하는 항체
TWI809004B (zh) 2017-11-09 2023-07-21 美商Ionis製藥公司 用於降低snca表現之化合物及方法
WO2019140231A1 (fr) 2018-01-12 2019-07-18 Bristol-Myers Squibb Company Oligonucléotides antisens ciblant l'alpha-synucléine et leurs utilisations
KR20210044220A (ko) 2018-07-11 2021-04-22 카 메디컬 리미티드 SIRPalpha-4-1BBL 변이체 융합 단백질 및 이의 사용 방법
CN109371143B (zh) * 2018-12-16 2021-05-07 华中农业大学 与猪生长性状相关联的snp分子标记
AU2020205735A1 (en) * 2019-01-11 2021-08-05 Minerva Biotechnologies Corporation Anti-variable MUC1* antibodies and uses thereof
CN111370057B (zh) * 2019-07-31 2021-03-30 深圳思勤医疗科技有限公司 确定样本染色体结构变异信号强度以及插入片段长度分布特征的方法及应用
CN110897989B (zh) * 2019-12-24 2021-11-26 广州蜜妆生物科技有限公司 一种敏感肌肤修复乳液
WO2022214635A1 (fr) * 2021-04-08 2022-10-13 Stichting Vu Molécules d'acide nucléique de compensation de l'haplo-insuffisance stxbp1 et leur utilisation dans le traitement de troubles liés à stxbp1
WO2023192883A2 (fr) * 2022-03-31 2023-10-05 Emory University Systèmes de capteur roulant pour détecter des analytes et méthodes de diagnostic associés à ceux-ci

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB230477A (fr) * 1924-03-06 1926-01-21 P. Gossen & Company Kommanditgesellschaft
US5166315A (en) * 1989-12-20 1992-11-24 Anti-Gene Development Group Sequence-specific binding polymers for duplex nucleic acids
US5217866A (en) * 1985-03-15 1993-06-08 Anti-Gene Development Group Polynucleotide assay reagent and method
US5235033A (en) * 1985-03-15 1993-08-10 Anti-Gene Development Group Alpha-morpholino ribonucleoside derivatives and polymers thereof
DE3650699T2 (de) * 1985-03-15 1999-04-15 Antivirals Inc Immunotestmittel für Polynukleotid und Verfahren
ATE143413T1 (de) * 1987-12-16 1996-10-15 Pasteur Institut Retinoesäurerezeptor und derivate davon, beide substanzen codierende dns und die verwendung der proteine und der dns
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US6433142B1 (en) * 1989-08-08 2002-08-13 Genetics Institute, Llc Megakaryocyte stimulating factors
JPH03147799A (ja) * 1989-11-02 1991-06-24 Hoechst Japan Ltd 新規なオリゴヌクレオチドプローブ
US5184444A (en) * 1991-08-09 1993-02-09 Aec-Able Engineering Co., Inc. Survivable deployable/retractable mast
SE9201929D0 (sv) * 1992-06-23 1992-06-23 Pharmacia Lkb Biotech Method and system for molecular-biological diagnostics
US5879898A (en) * 1992-11-20 1999-03-09 Isis Innovation Limited Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors
US5955272A (en) * 1993-02-26 1999-09-21 University Of Massachusetts Detection of individual gene transcription and splicing
US5714320A (en) * 1993-04-15 1998-02-03 University Of Rochester Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
GB2285445A (en) * 1993-12-06 1995-07-12 Pna Diagnostics As Protecting nucleic acids and methods of analysis
US5854033A (en) * 1995-11-21 1998-12-29 Yale University Rolling circle replication reporter systems
AU2253397A (en) * 1996-01-23 1997-08-20 Affymetrix, Inc. Nucleic acid analysis techniques
WO1998001148A1 (fr) * 1996-07-09 1998-01-15 President And Fellows Of Harvard College Utilisation de la proteine e2 du papillomavirus dans le traitement de cellules infectees par le papillomavirus, et compositions contenant cette proteine.
AU6721696A (en) * 1996-07-15 1998-03-06 Human Genome Sciences, Inc. Cd44-like protein
US5866080A (en) * 1996-08-12 1999-02-02 Corning Incorporated Rectangular-channel catalytic converters
WO1998018966A1 (fr) * 1996-10-31 1998-05-07 Jennifer Lescallett Amorces pour l'amplification de brca1
CA2273051A1 (fr) * 1996-12-03 1998-06-11 Prasanna Athma Predisposition au cancer du sein liee a des mutations affectant le locus du gene d'ataxie telangiectasie
JP2001508303A (ja) * 1997-01-13 2001-06-26 デイヴィッド・エイチ・マック 遺伝子機能同定のための発現モニタリング
US6492109B1 (en) * 1997-09-23 2002-12-10 Gene Logic, Inc. Susceptibility mutation 6495delGC of BRCA2
WO1999015704A1 (fr) * 1997-09-23 1999-04-01 Oncormed, Inc. Dosage par panel genetique pour determiner les mutations de predisposition dans le cancer du sein et des ovaires
JP2001521753A (ja) * 1997-10-31 2001-11-13 アフィメトリックス インコーポレイテッド 成人臓器及び胎児臓器中の発現プロフィール
AU1045199A (en) * 1997-11-05 1999-05-24 Isis Innovation Limited Cancer gene
JPH11169172A (ja) * 1997-12-08 1999-06-29 Hitachi Ltd Ｄｎａ塩基配列上のタンパク質コード領域予測方法及び記録媒体
EP1042470A2 (fr) * 1997-12-30 2000-10-11 Chiron Corporation Proteines secretees par la moelle osseuse et polynucleotides
WO1999039004A1 (fr) * 1998-02-02 1999-08-05 Affymetrix, Inc. Resequençage automatique
US6004755A (en) * 1998-04-07 1999-12-21 Incyte Pharmaceuticals, Inc. Quantitative microarray hybridizaton assays
CA2330731A1 (fr) * 1998-06-24 1999-12-29 Smithkline Beecham Corporation Procede pour detecter, analyser et cartographier les transcrits d'arn
AU5495600A (en) * 1999-06-17 2001-01-09 Fred Hutchinson Cancer Research Center Oligonucleotide arrays for high resolution hla typing

Also Published As

Publication number Publication date
EP1341930A2 (fr) 2003-09-10
WO2001057272A2 (fr) 2001-08-09
GB0216928D0 (en) 2002-08-28
GB2373500B (en) 2004-12-15
WO2001086003A8 (fr) 2002-05-16
GB0217805D0 (en) 2002-09-11
WO2001057278A3 (fr) 2003-01-09
WO2001057252A2 (fr) 2001-08-09
WO2001057273A8 (fr) 2002-02-28
WO2001057274A8 (fr) 2001-12-20
GB0217112D0 (en) 2002-09-04
EP1290217A2 (fr) 2003-03-12
GB2378754B (en) 2004-12-01
GB0218673D0 (en) 2002-09-18
AU2001230879A1 (en) 2001-08-14
WO2001057276A3 (fr) 2003-01-09
WO2001057271A8 (fr) 2001-12-06
GB2375539B (en) 2004-12-08
EP1325149A2 (fr) 2003-07-09
GB2385053A (en) 2003-08-13
AU2001230881A1 (en) 2001-08-14
AU2001232757A1 (en) 2001-08-14
AU2001232760A1 (en) 2001-08-14
WO2001057251A2 (fr) 2001-08-09
WO2001057278A2 (fr) 2001-08-09
GB2376018A (en) 2002-12-04
WO2001057277A2 (fr) 2001-08-09
EP1332224A2 (fr) 2003-08-06
GB0217714D0 (en) 2002-09-11
WO2001086003A2 (fr) 2001-11-15
GB0217835D0 (en) 2002-09-11
EP1309723A2 (fr) 2003-05-14
GB2382814B (en) 2004-12-15
WO2001057271A3 (fr) 2003-02-20
EP1309725A2 (fr) 2003-05-14
GB2383043B (en) 2005-07-27
EP1290216A2 (fr) 2003-03-12
GB2374872A (en) 2002-10-30
GB2383043A (en) 2003-06-18
GB2374929A (en) 2002-10-30
AU2001230883A1 (en) 2001-08-14
WO2001057274A3 (fr) 2003-05-08
GB2373500A (en) 2002-09-25
WO2001057275A2 (fr) 2001-08-09
WO2001057270A3 (fr) 2003-02-13
WO2001057272A3 (fr) 2003-01-03
GB2375539A (en) 2002-11-20
GB2382814A (en) 2003-06-11
WO2001057276A2 (fr) 2001-08-09
WO2001057275A9 (fr) 2002-10-17
WO2001057275A3 (fr) 2003-04-17
WO2001057270A2 (fr) 2001-08-09
GB0217188D0 (en) 2002-09-04
AU3087801A (en) 2001-08-14
WO2001057251A3 (fr) 2003-01-03
GB2375111B (en) 2004-12-01
GB2385053B (en) 2004-12-22
GB0217049D0 (en) 2002-08-28
GB2376237A (en) 2002-12-11
GB0217861D0 (en) 2002-09-11
GB2376018B (en) 2005-07-13
WO2001086003A3 (fr) 2003-05-22
WO2001057271A2 (fr) 2001-08-09
GB0217811D0 (en) 2002-09-11
AU2001232759A1 (en) 2001-08-14
WO2001057274A2 (fr) 2001-08-09
EP1325150A2 (fr) 2003-07-09
WO2001057251A9 (fr) 2002-10-31
WO2001057252A3 (fr) 2003-08-07
WO2001057273A3 (fr) 2003-06-26
GB2375111A (en) 2002-11-06
AU2001232758A1 (en) 2001-11-20
AU2001230880A1 (en) 2001-08-14
WO2001057277A3 (fr) 2003-02-13
EP1309724A2 (fr) 2003-05-14
WO2001057276A9 (fr) 2004-03-04
AU2001230882A1 (en) 2001-08-14
GB2378754A (en) 2003-02-19
US20020081590A1 (en) 2002-06-27
EP1292704A2 (fr) 2003-03-19
GB0123361D0 (en) 2001-11-21
WO2001057273A2 (fr) 2001-08-09
EP1292705A2 (fr) 2003-03-19
AU2001236589A1 (en) 2001-08-14

Similar Documents

Publication Publication Date Title
AU2001233114A1 (en) Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
AU2002307847A1 (en) System and method for extracting information
AU2002307436A1 (en) Method and system for data analysis
AU2003221884A8 (en) System and method for data analysis, manipulation, and visualization
AUPR372601A0 (en) Method and system for secure information
AU2002253366A1 (en) Method and system for providing user location information
AU3482200A (en) Methods for identifying drug targets based on genomic sequence data
AU2002249992A1 (en) Apparatus, method and system for multiple resolution affecting information access
AU2002220563A1 (en) Method, device and arrangement for inserting extra information
AU6052000A (en) Method, apparatus and system for providing health information
AU4028800A (en) Method for identifying accessible binding sites on rna
AU2002238114A1 (en) Apparatus and method for selecting data
AU2002236630A1 (en) System and method for organizing, navigating and analyzing data
EP1401204A4 (fr) Appareil et systeme de distribution d'informations, et procede correspondant
AU2001264634A1 (en) Method and apparatus for analyzing individual and comparative returns on assets
AU2001232025A1 (en) Methods and apparatus for obtaining positional information
AU2003259474A1 (en) Method for inputting character and position information
AU2001287487A1 (en) Method and apparatus for displaying information
AU2001211782A1 (en) Method and apparatus for inputting secret information
EP1182533A3 (fr) Dispositif, système et procédé d'amélioration de sécurité de données
AU2002356697A1 (en) Method and apparatus for retrieving relevant information
AU2002259216A1 (en) Analysis apparatus for genetic data
AU2002222622A1 (en) Electronic information burying method and extracting method, electronic information burying apparatus and extracting apparatus, and programs therefor
AU2001228992A1 (en) Method and apparatus for location event based information
AU2001280392A1 (en) Method and apparatus for location dependent information services